Marval Bioscience
San Diego, CA
www.marvalbioscience.com

Summary:
Next generation contrast agents for medical imaging.

Additional Information:
Marval Biosciences develops novel CT contrast agents that reduce toxicity to patients and improve imaging performance. These next generation contrast agents will enable a much broader population of patients to use CT for diagnosis of cardiovascular diseases without fear of contrast-induced nephropathy, which can cause acute kidney failure, particularly in elderly and diabetic patients. Based in San Diego, California and Houston, Texas, Marval was created through the licensing of intellectual property from the University of Texas Health Science Center at Houston, Georgia Institute of Technology, Case Western Reserve University, Cleveland State University and The University of Houston.